Open Access Open Access  Restricted Access Subscription or Fee Access

Evolution in Prostatic Biopsy for the Early Diagnosis of Prostate Cancer


(*) Corresponding author


Authors' affiliations


DOI's assignment:
the author of the article can submit here a request for assignment of a DOI number to this resource!
Cost of the service: euros 10,00 (for a DOI)

Abstract


Prostate biopsy is a diagnostic method that allows the collection of a quantity of prostate tissue useful for diagnosing prostate cancer. The advent of Multiparametric Magnetic Resonance is really changing the diagnostic and therapeutic prospects of the disease. In the early diagnosis of prostatic neoplasia, the multiparametric magnetic resonance imaging of the prostate associated with targeted prostatic biopsy using fusion imaging techniques can offer important advantages. Due to the most recent scientific evidence, multiparametric MRI (mp-RM) plays a fundamental role in the detection of prostate cancer in patients with clinical suspicion: the by now consolidated multiparametric protocol, which includes T2-weighted anatomical sequences, T1- weighed in perfusion (Dynamic Contrast Enhanced Magnetic Resonance Imaging, DCE-MRI) and diffusion-weighted (Diffusion Weighted Imaging, DWI) is able to provide a combination of anatomical, biological and functional information necessary for a more precise definition of suspicious lesions. Currently, the most heated debate is about what should be the timing for the execution of the RM.
Copyright © 2019 Praise Worthy Prize - All rights reserved.

Keywords


Prostatic Biopsy; Multiparametric MRI; Prostate Cancer

Full Text:

PDF


References


Rosenkrantz AB, Verma S, Choyke P, et al. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol 2016; 196(6): 1613-8.

Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 2015; 68(3): 438-50.

Nelson AW, Harvey RC, Parker RA, Kastner C, Doble A, Gnanapragasam VJ. Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy. PLoS One 2013; 8(2): e57480.

Kaufmann S, Russo GI, Bamberg F, et al. Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy. World J Urol 2018; 36(5): 761-8.

Tombal B. Toward the end of blind prostate biopsies? Eur Urol 2012; 62(6): 997-8; discussion 9-1000.

Penzkofer T, Tempany-Afdhal CM. Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective. NMR Biomed 2014; 27(1): 3-15.

Bjurlin MA, Meng X, Le Nobin J, et al. Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment. J Urol 2014; 192(3): 648-58.

Itatani R, Namimoto T, Atsuji S, et al. Negative predictive value of multiparametric MRI for prostate cancer detection: outcome of 5-year follow-up in men with negative findings on initial MRI studies. Eur J Radiol 2014; 83(10): 1740-5.

Puech P, Rouviere O, Renard-Penna R, et al. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. Radiology 2013; 268(2): 461-9.

Monda SM, Vetter JM, Andriole GL, et al. Cognitive Versus Software Fusion for MRI-Targeted Biopsy: Experience Before and After Implementation of Fusion. Urology 2018.

Le JD, Stephenson S, Brugger M, et al. Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. J Urol 2014; 192(5): 1367-73.

Washino S, Kobayashi S, Okochi T, et al. Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naive patients: a retrospective cohort study. BMC urology 2018; 18(1): 51.

Moore CM, Robertson NL, Arsanious N, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 2013; 63(1): 125-40.

Siddiqui MM, Rais-Bahrami S, Turkbey B, et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. Jama 2015; 313(4): 390-7.

Meng X, Rosenkrantz AB, Mendhiratta N, et al. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes. Eur Urol 2016; 69(3): 512-7.




Please send any question about this web site to info@praiseworthyprize.com
Copyright © 2005-2024 Praise Worthy Prize